CellaVision reinforces management team with a Chief Operating Officer

CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care services, has employed Stefan Bengtsson as Chief Operating Officer (COO). Mr Bengtsson will take up the position successively, starting on February 1, 2011. As COO Mr Bengtsson will have the overall responsibility for CellaVision's product supply, from development to delivery, and will be part of the management team reporting to CEO Yvonne MÃ¥rtensson. Mr Bengtsson has more than 20 years experience of medical device companies and has successfully led high-performing teams in both business and elite-level sport. "I'm very pleased that Stefan Bengtsson has decided to work with us. Stefan has strong leadership qualities and great knowledge of how to run product development and adapt production and organization in a vigorously growing company. Demand for our products is greater than ever and our challenge is to adapt our organization and processes to this strong growth in demand. The recruitment is part of our growth strategy," says Yvonne MÃ¥rtensson, CellaVision's CEO. Stefan Bengtsson holds a Masters degree in engineering and his most recent position was CEO of Presona AB, a leading supplier of compacting equipment in the recycling industry. He has held leading positions in Gambro, Getinge and Pharmacia and is a former player and trainer in the Swedish national league in bandy. For further information, please contact: Yvonne MÃ¥rtensson, CEO, CellaVision AB Telephone: 0708 33 77 82. Email:yvonne.martensson@cellavision.com About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2009 sales were SEK 109 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more atwww.cellavision.com This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: CellaVision AB via Thomson Reuters ONE [HUG#1478921]